V Wealth Advisors’s AbbVie ABBV Stock Holding History

V Wealth Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-700	Closed	-$76K	–	457
2021 Q3	$76K	Buy	+700	New	+$80K	0.01%	507

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

V Wealth Advisors's ABBV Position: Q3 2023 in Review

V Wealth Advisors reduced its AbbVie (ABBV) stake by 80% in Q3 2023, selling an estimated $1.7M and leaving 2,937 shares worth $438K. The position accounts for 0.35% of the portfolio, ranked #62.

V Wealth Advisors first reported a position in ABBV in Q3 2016 and has held it in 28 quarters since. The position peaked at $2.46M in Q1 2023. 3,108 funds tracked by Wall St. Rank hold ABBV as of Q3 2023.

V Wealth Advisors held 2,937 shares of AbbVie worth $438K as of Q3 2023.
V Wealth Advisors sold 11,606 AbbVie shares in Q3 2023, an estimated $1.7M.
AbbVie made up 0.35% of V Wealth Advisors's portfolio in Q3 2023, its #62 holding.
V Wealth Advisors first reported a position in AbbVie in Q3 2016 and has held it in 28 quarters since.
V Wealth Advisors's AbbVie position peaked at $2.46M in Q1 2023.
3,108 funds tracked by Wall St. Rank held AbbVie as of Q3 2023.

Based on V Wealth Advisors's 13F filing for Q3 2023, filed 15 Nov 2023.